Prof. Dr. Sezai VATANSEVER

Yayın Ağı

Makaleler 61

1. Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

Ozgun A., Mustafayev F. N. A., Dogan I., Vatansever S., Eryilmaz M. K., ERDOĞAN A. P., et al.

Molecular and Clinical Oncology , cilt.22, sa.6, 2025 (ESCI) Sürdürülebilir Kalkınma

2. Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1

Dogan I., AHMED M. A., YILDIZ A., Vatansever S.

INDIAN JOURNAL OF SURGICAL ONCOLOGY , sa.3, ss.484-488, 2024 (ESCI) Sürdürülebilir Kalkınma

3. Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients

Dogan I., Yıldız A., Ahmed M. A., Vatansever S.

Indian Journal of Surgical Oncology , cilt.15, sa.3, ss.489-494, 2024 (ESCI, Scopus)

4. Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer

Topal E., Has Simsek D., Vatansever S., Sanli Y., Kuyumcu S.

CLINICAL NUCLEAR MEDICINE , cilt.49, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST

KIZILDAĞ YIRGIN İ., Dogan I., Engin G., Vatansever S., ERTÜRK Ş. M.

Journal of Cancer Research and Therapeutics , cilt.20, sa.1, ss.156-162, 2024 (SCI-Expanded)

6. Efficacy of Intrathecal Therapy In Breast Cancer Patients With Leptomeningeal Metastasis

Khanmammadov N., Dogan I., AHMED M. A., YILDIZ A., Nizam N., KHISHIGSUREN B., et al.

Eastern Journal of Medicine , cilt.29, sa.4, ss.503-508, 2024 (Scopus, TRDizin)

7. Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study

FERHATOĞLU F., ÇAĞATAY T., OKUMUŞ G., AYDINER A., PAKSOY N., VATANSEVER S., et al.

Eurasian Journal of Medical Investigation , cilt.7, sa.2, ss.101-106, 2023 (TRDizin)

8. Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors

DOĞAN İ., KHANMAMMADOV N., PAKSOY N., VATANSEVER S., SAİP P., AYDINER A.

Eurasian Journal of Pulmonology , cilt.25, sa.1, ss.27-32, 2023 (Hakemli Dergi)

9. Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated with A Combination of Lapatinib and Capecitabine

DOĞAN İ., Paksoy N., AK N., VATANSEVER S., Saip P., AYDINER A.

European Journal of Breast Health , cilt.19, sa.2, ss.128-133, 2023 (Scopus, TRDizin)

10. **Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors**

Dogan I., Khanmammadov N., Yildiz A., AHMED M. A., Vatansever S., SAİP P. M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.19, sa.7, ss.1945-1949, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. The Significance of Preoperative Computed Tomography Features in the Prediction of Overall Survival in Gastric Cancer: A Retrospective Analysis

Kızıldağ Yırgın İ., Dogan İ., Vatansever S., Erturk Ş. M.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , sa.1, ss.1-5, 2023 (Hakemli Dergi)

12. Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Yekeduz E., Dogan I., Kaya D. M., Ozgur I., UTKAN G., Vatansever S., et al.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.53, sa.4, ss.870-879, 2022 (ESCI, Scopus) Sürdürülebilir Kalkınma

13. Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC

DOĞAN İ., Gurbuz M., Paksoy N., Ferhatoglu F., Vatansever S., Saip P., et al.

MEDICINE , cilt.101, sa.34, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib

DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.

CLINICAL CANCER INVESTIGATION JOURNAL , sa.4, ss.5-9, 2022 (ESCI)

15. Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.

Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience

DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.

CLINICAL CANCER INVESTIGATION JOURNAL , sa.3, ss.25-29, 2022 (ESCI)

17. Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib

Dogan I., Khanmammadov N., Paksoy N., Ferhatoglu F., Aydın E., Vatansever S., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, ss.413-418, 2022 (ESCI, Scopus)

18. Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer

Ak N., Vatansever S.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.46, sa.6, ss.1787-1791, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center

Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY , cilt.29, sa.4, ss.487-495, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

20. Metastases to the Stomach: Clinicopathologic Features of Metastases Mimicking Gastric Primaries

ALTAY A. Y., BÜYÜK M., ÖZGÜR İ., GÖK A. F. K., ÇAVUŞ B., AYDIN E., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.37, sa.3, ss.203-211, 2021 (ESCI, Scopus, TRDizin)

21. Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors.

Aydiner A., Dogan I., Khanmammadov N., Saip P., Vatansever S.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib

Dogan I., Khanmammadov N., Paksoy N., Ferhatoglu F., Aydin E., Vatansever S., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.16, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Predictors of treatment response in ALK-positive metastatic non-small cell lung cancer

Dogan I., Gurbuz M., Paksoy N., Ferhatoglu F., Vatansever S., Saip P., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.16, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.

Dogan I., Iribas A., Paksoy N., Ekenel M., Vatansever S., Basaran M.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded, Scopus)

25. "Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic

Ak N., Vatansever S.

CHEMOTHERAPY , cilt.65, sa.5-6, ss.141-146, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer

Ak N., Serilmez M., Ucuncu M. Z., Bademler S., Vatansever S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, sa.2, ss.165-170, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

27. Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, ss.438-445, 2021 (ESCI)

28. The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer

Avsar M., Tambas M., Yalniz Z., Akdeniz D., Tuncer S., Kilic S., et al.

MOLECULAR BIOLOGY REPORTS , sa.4, ss.4001-4008, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Vemurafenib-induced toxic epidermal necrolysis: Is it an emerging side-effect of the drug?

Kilic S., Ozkaya E., Baykal C., Vatansever S.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.31, 2017 (SCI-Expanded, Scopus)

30. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded, Scopus)

31. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.

TUMOR BIOLOGY , cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S., Aksit E., Tas F., Ciftci R., Aydiner A., Yildiz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.35, sa.5, ss.4323-9, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Rare pancreas tumor mimicking adenocarcinoma: Extramedullary plasmacytoma

AKYÜZ F., Sahin D., Akyuz U., VATANSEVER S.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , cilt.6, sa.3, ss.99-100, 2014 (ESCI)

35. Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , cilt.35, sa.3, ss.2327-2333, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY , cilt.35, sa.3, ss.2729-2739, 2014 (SCI-Expanded, Scopus)

37. High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

Ciftci R., Tas F., Yasasever C., Aksit E., Karabulut S., Sen F., et al.

Tumor Biology , cilt.35, sa.7, ss.6941-6948, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. The Role of Surgical Methods in the Treatment of Anorectal Malignant Melanoma (AMM)

Keskin S., Tas F., Karabulut S., Yildiz I., Kilic L., Ciftci R., et al.

ACTA CHIRURGICA BELGICA , cilt.113, sa.6, ss.429-433, 2013 (SCI-Expanded, Scopus)

39. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.

Keskin S., Tas F., Ekenel M., Kilic L., Sen F., Yildiz I., et al.

Tumori , cilt.99, sa.4, ss.463-8, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.

Keskin S., Tas F., Vatansever S.

Urologia internationalis , cilt.90, sa.4, ss.435-8, 2013 (SCI-Expanded, Scopus)

41. A CASE OF PARANEOPLASTIC LIMBIC ENCHEPHALITIS DUE TO GASTRIC CARCINOMA PRESENTING WITH PANHYPOPITUITARISM

Kayacan S., Vatansever S., Yilmaz A., Kayacan D., Karadag A., Akkaya V., et al.

NOBEL MEDICUS , cilt.9, sa.1, ss.121-123, 2013 (SCI-Expanded, Scopus)

42. Factors Associated with Late Toxicity in Nasopharyngeal Carcinoma Patients Treated with Radio-Chemotherapy

Meral R., Camlica H., Vatansever S.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.30, sa.1, ss.37-47, 2010 (SCI-Expanded, Scopus)

43. High Sensitivity C- Reactive Protein In Spontaneous Bacterial Peritonitis with Nonneutrocytic Ascites

Guler K., Vatansever S., Kayacan S. M., Salmayenli N., Akkaya V., Erk O., et al.

HEPATO-GASTROENTEROLOGY , cilt.56, sa.90, ss.452-455, 2009 (SCI-Expanded)

44. A CASE OF LEPTOSPIROSIS PRESENTING WITH NEPHROTIC SYNDROME, ACUTE RENAL FAILURE AND THROMBOCYTOPENIA

Kayacan S. M., VATANSEVER S., Karada A., ERK O., Kilic L., Bal H., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.72, sa.1, ss.25-28, 2009 (ESCI, TRDizin)

45. Alveolar echinococcosis localized in the liver, lung and brain

Kayacan S. M., Vatansever S., Temiz S., Uslu B., Kayacan D., Akkaya V., et al.

CHINESE MEDICAL JOURNAL , sa.1, ss.90-92, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. A CASE OF COPPER SULFATE INTOXICATION THAT IS PRESENTED WITH PROLONGED HEMOLYSIS AND ACUTE RENAL FAILURE

Kayacan S. M., VATANSEVER S., Akkaya V., ERK O., Tukek T., KILIÇASLAN I., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.2, ss.47-50, 2007 (ESCI)

47. A case of inflammatory pseudotumor in the spleen

CELEBI A., Kayacan S. M., Keskin S., TEMELOGLU E., KOC D., ERCAN V., et al.

SOUTHERN MEDICAL JOURNAL , cilt.99, sa.7, ss.774-776, 2006 (SCI-Expanded, Scopus)

48. The effect of air pollution and meteorological parameters on chronic obstructive pulmonary disease at an Istanbul hospital

Hapcioglu B., Issever H., Kocyigit E., Disci R., Vatansever S., OZDILLI K.

INDOOR AND BUILT ENVIRONMENT , cilt.15, sa.2, ss.147-153, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids

OKTEM G., Vatansever S., AYLA S., UYSAL A., AKTAS S., KARABULUT B., et al.

ONCOLOGY REPORTS , cilt.15, sa.2, ss.335-340, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. The effect of air pollution and meteorological parameters in Istanbul on hospital admissions for acute coronary syndrome

Issever H., Disci R., HAPCIOGLU B., Vatansever S., Karan M. A., Akkaya V. A., et al.

INDOOR AND BUILT ENVIRONMENT , cilt.14, sa.2, ss.157-164, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. CANDIDA KEFYR PNEUMONIA

Kocabay G., Aydin S., Tiryak B., VATANSEVER S., ERK O., Akkaya V., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.68, sa.1, ss.26-28, 2005 (ESCI, TRDizin)

52. A CASE OF METHEMOGLOBINEMIA INDUCED BY THE ADMINISTRATION OF PRILOCAINE PRIOR TO AN EPILATION PROCEDURE

Turkmen E., Kocabay G., YAVUZ A. F., ÖZTÜRK S., VATANSEVER S., Akkaya V., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.68, sa.1, ss.19-21, 2005 (ESCI)

53. UNILATERAL RENALARTERY THROMBOEMBOLISM IN A PATIENT WITH ATRIAL FIBRILLATION

ELİTOK A., Yilmaz C., Karakaya D., Barman A., VATANSEVER S., Akkaya V., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.68, sa.2, ss.53-55, 2005 (ESCI, TRDizin)

54. Pre-ischemic administration of nitric oxide synthase inhibitors reduced germ cell apoptosis after spermatic vessel ligation in the rat testis

Taneli F., VATANSEVER S., Ulman C., Giray G., Genc A., Taneli C.

UROLOGIA INTERNATIONALIS , cilt.75, sa.1, ss.70-74, 2005 (SCI-Expanded, Scopus)

55. Evde Hazırlanmış Konserve Bezelye Yenilmesi Sonucu Tip A Nörotoksinine Bağlı Botulism Vakası

TÜRKMEN E., KOCABAY G., SOYLUK SELÇUKBİRİCİK Ö., VATANSEVER S., GÜLER K., AKKAYA V. A., et al.

İstanbul Tıp Fakültesi Mecmuası , 2003 (Hakemli Dergi)

56. Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers

Ucur A., Palanduz S., Cefle K., Ozturk Ş., Tutkan G., Vatansever S., et al.

HEPATO-GASTROENTEROLOGY , cilt.50, sa.54, ss.2137-2140, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Rheological properties of blood in patients with chronic liver disease

Tamer S., Cefle K., Palanduz S., Vatansever S.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION , cilt.26, sa.1, ss.9-14, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Questioning the psycho-socio-cultural factors that contribute to the cases of suicide attempts: an investigation

Tüzün B., Polat O., Vatansever S., Elmas I.

FORENSIC SCIENCE INTERNATIONAL , cilt.113, ss.297-301, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. A case of Noonan syndrome with pulmonary and abdominal lymphangiectasia

Ozturk Ş., Cefle K., Palanduz S., Erten N., Karan M., Tascioglu C., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.54, sa.4, ss.274-276, 2000 (SCI-Expanded, Scopus)

60. Rheological properties of blood in patients with ischaemic heart disease

Palanduz S., Tamer S., Vatansever S., Karan M., Cefle K., Ozturk Ş., et al.

MEDICAL SCIENCE RESEARCH , cilt.27, sa.5, ss.327-329, 1999 (SCI-Expanded, Scopus)

61. Total antioxidant status, lipid parameters, lipid peroxidation and glutathione levels in patients with acute myocardial infarction

Guler K., Palanduz S., Ademoglu E., Salmayenli N., Gokkusu C., Vatansever S.

MEDICAL SCIENCE RESEARCH , cilt.26, sa.2, ss.105-106, 1998 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 31

1. Non-operative management in locally advanced distal rectal cancer patients with clinical complete response after consolidation chemoradiotherapy: A single center experience

Kulle C. B., Özgür İ., Bayraktar A., Güden İ., Karaman Ş., Vatansever S., et al.

ESCP 17th Scientific & Annual Meeting, Dublin, İrlanda, 21 - 23 Eylül 2022, cilt.24, sa.1, ss.1-315, (Özet Bildiri)

2. Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis

Dogan I., Kızıldağ Yırgın İ., Özkurt S., İbiş K., Vatansever S., Saip P. M., et al.

2022 ASCO Annual Meeting , Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2022, ss.14002, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Evaluation of the relationship between clinicopathological features at diagnosis and acquisition of T790M resistance mutation in patients with EGFR-mutant metastatic lung cancer

Dogan I., Khanmamadov N., Paksoy N., Vatansever S., Saip P., Aydiner A.

Molecular Analysis for Precision Oncology Virtual Congress, ELECTR NETWORK, 7 - 09 Ekim 2021, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

Dogan I., Gurbuz M., Paksoy N., Khanmamadov N., Vatansever S., Saip P., et al.

Molecular Analysis for Precision Oncology Virtual Congress, ELECTR NETWORK, 7 - 09 Ekim 2021, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

5. The Significance Of Preoperative Computed Tomography Features In The Prediction Of Overall Survival In Gastric Cancer: A Retrospective Analysis.

Kızıldağ Yırgın İ., Erturk S. M., Dogan I., Vatansever S.

ECR2021, Vienna, Avusturya, 3 - 07 Mart 2021, ss.10-11, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. iRECIST, irRC and irRECIST: A Pairwise Agreement and Performance Evaluation Study

Kızıldağ Yırgın İ., Doğan İ., Vatansever S., Ertürk Ş. M.

RSNA2020, Illinois, Amerika Birleşik Devletleri, 24 - 29 Kasım 2020, ss.988, (Tam Metin Bildiri)

7. BAĞIŞIKLIK KONTROL NOKTASI İNHİBİTÖRLERİ: İRECIST, İRRC VE İRRECIST’İN PERFORMANSLARININ VE UYUMLARININ DEĞERLENDİRİLMESİ IMMUNE CHECKPOİNT İNHİBİTORS: ASSESSMENT OF THE PERFORMANCE AND THE AGREEMENT OF İRECIST, İRRC AND İRRECIST

Kızıldağ Yırgın İ., Doğan İ., Vatansever S., Ertürk Ş. M.

41.Ulusal Radyoloji Kongresi, Antalya, Türkiye, 24 Ekim - 01 Kasım 2020, ss.205-206, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

8. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer

Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

9. 3 Boyutlu brakiterapi ile tedavi edilen endometriium kanserli hastalarda akut ve geç yan etki değerlendirmesi

İBİŞ K., KÜÇÜCÜK N. S., GÜRDAL N., ENGİN G., VATANSEVER S., TOPUZ S., et al.

22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)

10. Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.

3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

11. Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Prognostic roles of serum NEDD9 levels in patients with gastric cancer.

Karabulut S., Karabulut M., Alis H., Bozbey H. U., Sakar B., Vatansever S., et al.

13. Clinical significance of serum claudin-7 levels in patients with colorectal cancer.

Aydogan F., Karabulut M., Alis H., Karabulut S., Celebi K., Bozbey H. U., et al.

14. Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

Basaran M., KARABULUT S., KARABULUT M., GUNALDI M., ALIS H., Erturk K., et al.

15. Clinical significance of serum vascular cell adhesion molecule-1(VCAM-1) in colorectal cancer

Ciftci R., Aykan N. F., Aksit E., YASASEVER C. T., Vatansever S., Yasasever V.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 15 - 17 Ocak 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Clinical significance of serum transforming growth factor beta 1 (TGFB1) level in breast cancer.

CIFTCI R., Tas F., Kilic L., Vatansever S., KARABULUT S.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

18. AKCİĞER KANSERLİ HASTALARDA FİBULİN-2 GENİNİN ARAŞTIRILMASI

avşar m., AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., çiftçi r., DAĞOĞLU R. N., ahmedova a., et al.

6. ulusal akciğer kanser kongresi, Antalya, Türkiye, 8 - 11 Mayıs 2014, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

19. Meme Kanserli Hastalarda Serum Par-1 (Protease Activated Receptor-1) Düzeylerinin Klinik Açıdan Önemi

Ciftci R., Karabulut S., Aksit E., TAŞ F., TİLGEN YASASEVER C., VATANSEVER S., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.500, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

20. Epitelyal Over Kanserli Hastalarda Yüksek Serum Epidermal Büyüme Faktör Reseptörü (EGFR) Düzeyleri Kötü Progresyonsuz Sağkalımla İlişkilidir

Karabulut S., Ciftci R., Tastekin D., TİLGEN YASASEVER C., VATANSEVER S., Duranyildiz D., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.428, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

21. Serum Transforme Edici Büyüme Faktörü-Beta1 (TGF-B1) Seviyelerinin Epitelyal Over Kanserli Hastalarda Klinik Önemi

Karabulut S., Ciftci R., Tastekin D., VATANSEVER S., TAŞ F., TİLGEN YASASEVER C., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.421, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

22. Meme Kanserli Hstalarda Serum MIF (Macrophage Migration Inhibitory Factor) Düzeylerinin Klinik Açıdan Önemi

Ciftci R., Karabulut S., TİLGEN YASASEVER C., Aksit E., Yildiz I., BİLGİN DOĞRU E., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.501, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

23. Serum Hücresel Adhezyon Molekülleri (VCAM-1, EPCAM) Seviyelerinin Meme Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü

Karabulut S., Ciftci R., Tastekin D., VATANSEVER S., Aydiner A., TİLGEN YASASEVER C., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.493, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

24. Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma

Karabulut S., Aykan N. F., Yildiz I., Kilic L., Sen F., Vatansever S.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 16 - 18 Ocak 2014, cilt.32, (Özet Bildiri)

25. Clinical significance of coagulation assays in metastatic pancreas adenocarcinoma

VATANSEVER S., Tas F., Yildiz I., Kilic L., Ciftci R., Karabulut S., et al.

7th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, ss.600-601, (Tam Metin Bildiri)

26. Prognostic factors in metastatic pancreatic cancer: Older patients have poorer prognosis

Ciftci R., Karabulut S., Aydogan F., Kilic L., Keskin S., Yildiz I., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) Sürdürülebilir Kalkınma